1                                     Use of a potassium-sparing diuretic, alone or in combination with

2 sessed whether addition or substitution of a potassium-sparing diuretic, amiloride, to treatment with

3 th in hypertensive patients treated with non-potassium-sparing diuretics is reported.

4 losing tubulopathy, are usually treated with potassium-sparing diuretics or nonsteroidal anti-inflamm

5           We sought to determine whether non-potassium-sparing diuretics (PSDs) in the absence of a P

6 While blockade of ASIC1 through amiloride, a potassium sparing diuretic that is currently licensed fo

7                                     Only non-potassium-sparing diuretic use was independently associa

8  Conclusions-In SOLVD, baseline use of a non-potassium-sparing diuretic was associated with an increa

9  arrhythmic death, whereas baseline use of a potassium-sparing diuretic was not.

10 diuretic, alone or in combination with a non-potassium-sparing diuretic, was not independently associ